Social media may complement traditional data sources to answer comparative effectiveness/safety questions after medication licensure.
The Treato platform was used to analyze all publicly available social media data including Facebook, blogs, and discussion boards for posts mentioning inflammatory arthritis (e.g. rheumatoid, psoriatic). Safety events were self-reported by patients and mapped to medical ontologies, resolving synonyms. Disease and symptom-related treatment indications were manually redacted. The units of analysis were unique terms in posts. Pre-specified conditions (e.g. herpes zoster (HZ)) were selected based upon safety signals from clinical trials and reported as pairwise odds ratios (ORs); drugs were compared with Fisher’s exact test. Empirically identified events were analyzed using disproportionality analysis and reported as relative reporting ratios (RRRs). The accuracy of a natural language processing (NLP) classifier to identify cases of shingles associated with arthritis medications was assessed.
As of October 2015, there were 785,656 arthritis-related posts. Posts were predominantly US posts (75%) from patient authors (87%) under 40 years of age (61%). For HZ posts (n = 1815), ORs were significantly increased with tofacitinib versus other rheumatoid arthritis therapies. ORs for mentions of perforated bowel (n = 13) were higher with tocilizumab versus other therapies. RRRs associated with tofacitinib were highest in conditions related to baldness and hair regrowth, infections and cancer. The NLP classifier had a positive predictive value of 91% to identify HZ. There was a threefold increase in posts following television direct-to-consumer advertisement (p = 0.04); posts expressing medication safety concerns were significantly more frequent than favorable posts.
Social media is a challenging yet promising data source that may complement traditional approaches for comparative effectiveness research for new medications.
Jain G, Sharma M. Social Media: A Review. In: Satapathy S, Mandal J, Udgata S, Bhateja V. (eds) Information Systems Design and Intelligent Applications. Advances in Intelligent Systems and Computing, vol 433. Springer: New Delhi; 2016. p. 387-95.
O'Neill RT, Szarfman A. Some FDA perspectives on data mining for pediatric safety assessment. Workshop on adverse drug events in pediatrics. Curr Ther Res Clin Exp. 2001;62:650–63. CrossRef
https://treato.com/. Accessed 20 Feb 2017.
http://corp.treato.com/technology. Accessed 20 Feb 2017.
The Healthcare Hashtag Project. Symplur. N.p., n.d. Web. 26 May 2016.
Sanford A. “I can air my feelings instead of eating them”: blogging as social support for the morbidly obese. Communication Studies. 2010;61(5):567–84. CrossRef
Yang CC, Yang H, Jiang L. Postmarketing drug safety surveillance using publicly available health-consumer-contributed content in social media. TMIS. 2014;5(1):2.
Pierce CE, et al. Evaluation of Facebook and Twitter Monitoring to Detect Safety Signals for Medical Products: An Analysis of Recent FDA Safety Alerts. Drug Safety. 2017;1-15.
Bahk CY, Cumming M, Paushter L, Madoff LC, Thomson A, Brownstein JS. Publicly available online tool facilitates real-time monitoring of vaccine conversations and sentiments. Health Aff (Millwood). 2016;35(2):341–7. CrossRef
Ledford C, Anderson L. Online social networking in discussions of risk: applying the CAUSE model in a content analysis of Facebook. Health Risk Soc. 2013;15(3):251–64. CrossRef
http://pharmamkting.blogspot.com/2016/03/annual-spending-on-directto-consumer.html. Accessed 20 Feb 2017.
Bravo CA, Hoffman-Goetz L. Social Media and Men’s Health A Content Analysis of Twitter Conversations During the 2013 Movember Campaigns in the United States, Canada, and the United Kingdom. Am J Mens Health. 2015;1557988315617826.
Sullivan HW, O'Donoghue AC, Amie C, Aikin KJ. Communicating benefit and risk information in direct-to-consumer print advertisements: a randomized study. Ther Innov Regul Sci. 2015;49(4):493–502. CrossRef
Duggan M. The Demographics of Social Media Users. Pew Research Center: Internet, Science & Tech. Pew Research Center, 19 Aug. 2015. Web. 20 Feb 2017.
Klint F. Twitter CEO Jack Dorsey Hints Its 140 Character Limit Could End. Wired. Conde Nast, 05 Jan. 2016. Web. 20 Feb 2017. http://www.wired.com/2016/01/twitter-ceo-jack-dorsey-hints-its-140-character-limit-could-end/. Accessed 20 Feb 2017.
- Social media for arthritis-related comparative effectiveness and safety research and the impact of direct-to-consumer advertising
Jeffrey R. Curtis
W. Benjamin Nowell
- BioMed Central
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II